secwatch.observer — SEC 8-K summary
======================================

Issuer:     GLOBUS MEDICAL INC (GMED)
CIK:        0001237831
Form:       8-K
Filed at:   2026-08-06T20:19:48+00:00
Accession:  0001628280-26-054353
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Globus Medical Q2 net sales $789.6M (+5.9%); non-GAAP EPS $1.34 (+55.8%), raises FY EPS guidance
--------------------------------------------------------------------------------

- Worldwide net sales $789.6M, +5.9% YoY; US +3.0%, International +18.0% as-reported.
- GAAP diluted EPS $1.10 (-26.2% YoY) due to prior-year bargain purchase gain; non-GAAP diluted EPS $1.34 (+55.8%).
- US Spine grew 7% YoY; International Spine grew 14% as-reported (12% constant currency).
- Adjusted gross margin expanded 200 bps YoY; record Q2 non-GAAP net income and EPS.
- FY2026 revenue guidance reaffirmed $3.18B-$3.22B; non-GAAP EPS guidance raised to $4.95-$5.05 from $4.70-$4.80.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1237831/000162828026054353/0001628280-26-054353-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1237831/000162828026054353/gmed-20260806.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-054353

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer